• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.

Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Am J Med. 2020 10; 133(10):1187-1194.

View in: PubMed

subject areas
  • Adrenergic beta-Antagonists
  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Atrial Fibrillation
  • Cardiotonic Agents
  • Cause of Death
  • Digoxin
  • Female
  • Heart Failure
  • Hospitalization
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Male
  • Mineralocorticoid Receptor Antagonists
  • Mortality
  • Patient Readmission
  • Platelet Aggregation Inhibitors
  • Propensity Score
  • Proportional Hazards Models
  • Registries
  • Sodium Potassium Chloride Symporter Inhibitors
  • Stroke Volume
  • Warfarin

authors with profiles
  • Michael R. Zile